pindolol has been researched along with Hearing Loss, Sensorineural in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kugler, BT | 1 |
| Caudrey, DJ | 1 |
| Gruzelier, JH | 1 |
1 trial available for pindolol and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
Bilateral auditory acuity of schizophrenic patients: effects of repeated testing, time of day and medication.
Topics: Adult; Auditory Threshold; Clinical Trials as Topic; Dominance, Cerebral; Female; Functional Lateral | 1982 |